The bHLH transcription factor BIS1 controls the iridoid branch of the monoterpenoid indole alkaloid pathway in Catharanthus roseus by Moerkercke, A. van et al.
The bHLH transcription factor BIS1 controls the iridoid
branch of the monoterpenoid indole alkaloid pathway
in Catharanthus roseus
Alex Van Moerkerckea,b, Priscille Steensmac, Fabian Schweizera,b, Jacob Polliera,b, Ivo Gariboldic, Richard Payned,
Robin Vanden Bosschea,b, Karel Miettinena,b, Javiera Espozc, Purin Candra Purnamac, Franziska Kellnerd,
Tuulikki Seppänen-Laaksoe, Sarah E. O’Connord, Heiko Rischere, Johan Memelinkc, and Alain Goossensa,b,1
aDepartment of Plant Systems Biology, Flanders Institute for Biotechnology (VIB), 9052 Gent, Belgium; bDepartment of Plant Biotechnology and
Bioinformatics, Ghent University, 9052 Gent, Belgium; cInstitute of Biology, Leiden University, 2300 RA Leiden, The Netherlands; dDepartment of Biological
Chemistry, John Innes Centre, Norwich NR4 7UH, United Kingdom; and eVTT Technical Research Centre of Finland Ltd., FIN-02044 VTT, Espoo, Finland
Edited by Richard A. Dixon, University of North Texas, Denton, TX, and approved May 29, 2015 (received for review March 17, 2015)
Plants make specialized bioactive metabolites to defend them-
selves against attackers. The conserved control mechanisms are
based on transcriptional activation of the respective plant species-
specific biosynthetic pathways by the phytohormone jasmonate.
Knowledge of the transcription factors involved, particularly in
terpenoid biosynthesis, remains fragmentary. By transcriptome
analysis and functional screens in the medicinal plant Catharan-
thus roseus (Madagascar periwinkle), the unique source of the
monoterpenoid indole alkaloid (MIA)-type anticancer drugs vin-
cristine and vinblastine, we identified a jasmonate-regulated basic
helix–loop–helix (bHLH) transcription factor from clade IVa induc-
ing the monoterpenoid branch of the MIA pathway. The bHLH
iridoid synthesis 1 (BIS1) transcription factor transactivated the
expression of all of the genes encoding the enzymes that catalyze
the sequential conversion of the ubiquitous terpenoid precursor
geranyl diphosphate to the iridoid loganic acid. BIS1 acted in a
complementary manner to the previously characterized ethylene
response factor Octadecanoid derivative-Responsive Catharanthus
APETALA2-domain 3 (ORCA3) that transactivates the expression of
several genes encoding the enzymes catalyzing the conversion of
loganic acid to the downstream MIAs. In contrast to ORCA3, over-
expression of BIS1 was sufficient to boost production of high-
value iridoids and MIAs in C. roseus suspension cell cultures.
Hence, BIS1 might be a metabolic engineering tool to produce
sustainably high-value MIAs in C. roseus plants or cultures.
basic helix loop helix | Catharanthus roseus | jasmonate |
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Plants produce a vast amount of natural products, also calledspecialized metabolites, by which they can interact with their
environment to ensure survival and reproductive success. These
compounds often have bioactive properties that make them
valuable for various pharmaceutical applications. The phyto-
hormone jasmonate (JA) acts as an elicitor of the production of
these bioactive metabolites and triggers a transcriptional re-
programming of plant metabolism, resulting in a concerted up-
regulation of the expression of genes encoding enzymes involved
in specific specialized metabolic pathways (1). The specialized
defense metabolites are generally produced from primary me-
tabolites, leading to precursor competition with cellular pro-
cesses implicated in growth and development. For instance,
terpenoid biosynthesis depends on the precursor isopentenyl
diphosphate (IPP), which is produced either via the plastidial
2-C-methyl-D-erythritol 4-phosphate (MEP) or the cytosolic
mevalonate (MVA) pathways (Fig. 1A). In the medicinal plant
Catharanthus roseus (Madagascar periwinkle), the MEP path-
way-derived IPP is one of the precursors of the monoterpenoid
indole alkaloid (MIA) pathway that leads to the valuable anti-
cancer molecules vincristine and vinblastine, of which C. roseus
is the sole source (2–4), whereas the MVA-derived IPP is the
precursor of the pentacyclic triterpenoid pathway (5, 6) (Fig.
1A). As IPP is also the precursor for the synthesis of gibberellins,
brassinosteroids, phytosterols, carotenoids, and phytol, among
others, the tight regulation of both IPP supply and consumption
is crucial.
In C. roseus, the MEP-derived production of the mono-
terpenoid, more specifically seco-iridoid, compound secologanin
involves 10 enzymatic conversions starting from IPP, of which the
eight genes upstream of loganic acid methyltransferase (LAMT) are
tightly coexpressed (Fig. 1) (2, 3, 7). Secologanin is subsequently
coupled to the indole compound tryptamine, forming the common
alkaloid precursor strictosidine, from which all MIAs are derived
(Fig. 1A). In contrast to the triterpenoid genes in C. roseus, genes
involved in MIA production are JA inducible, clearly pointing to
distinct regulatory circuits governing these two terpenoid pathways
(Fig. 1) (8).
The concerted regulation of JA-induced genes is mediated by
transcription factors (TFs) that are usually encoded by JA-in-
ducible genes themselves (1). A combinatorial role for several
TFs seems a plausible strategy for the control of biosynthetic
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pathways by JAs, but the identity of such TF arrays has so far
remained elusive for most terpenoid pathways (1). The basic
helix–loop–helix (bHLH) TF MYC2 has emerged as a central
regulator in JA signaling cascades, including those leading to the
biosynthesis of several classes of specialized metabolites (9).
MYC2-type TFs have been shown to be involved in the regula-
tion of terpene biosynthesis genes in Arabidopsis thaliana, Arte-
misia annua (sweet wormwood), and Solanum lycopersicum
(tomato) (10–12). In C. roseus, MYC2 regulates the expression
of the ethylene response factor (ERF) Octadecanoid derivative-
Responsive Catharanthus APETALA2-domain 3 (ORCA3) (13),
the JA-inducible regulatory TF that modulates the JA-induced
expression of the genes of the indole branch of the pathway,
strictosidine synthase (STR), and several steps downstream of
strictosidine, thereby controlling part of the JA-responsive pro-
duction of MIAs (14, 15). However, the iridoid genes upstream of
LAMT, such as geraniol-8-oxidase (G8O), are not under the control
of ORCA3 (Fig. 1) (14) but are clearly responsive to JA, as il-
lustrated by transcriptome (8, 14) andG8O promoter (16) analysis,
suggesting that several regulatory circuits might exist that drive
divergent gene expression in the MIA pathway. These circuits
probably involve both repressors and activators, such as the pre-
viously studied C. roseus G-box binding factors (GBFs),
WRKY1, AT-hook, and zinc finger TFs (17–20), or TFs that in-
teract with MYC2, for instance, as reported in Arabidopsis (21, 22).
As the accumulation of MIAs is low, leading to scarcity and
high market prices, there is a general interest to boost the pro-
duction of these compounds in planta. The use of TFs can be a
powerful tool in such metabolic engineering programs. ORCA3
has been overexpressed in cell suspensions, hairy roots, and
plants in attempts to increase MIA production (14, 23–25).
However, because ORCA3 does not activate iridoid genes, MIA
accumulation in these lines required either coexpression with
G8O or feeding with iridoid precursors. Given the rate-limiting
nature of the iridoid pathway in C. roseus cultures, we launched
a screen, based on transcriptome analysis, to discover iridoid-
regulating TFs.
Results
Identification of a pG8O-Transactivating TF. To identify regulators
of the iridoid pathway branch, we set up a screen for trans-
activators of the G8O promoter (pG8O), the sequence of which
had been determined previously (16). Candidate TFs were se-
lected by mining recently generated RNA-Seq data (7, 8, 26) for
TFs that showed coexpression with the iridoid genes upstream
of LAMT. Essentially, TF encoding genes that showed expres-
sion patterns similar to G8O in the RNA-Seq data generated
by the SmartCell consortium (bioinformatics.psb.ugent.be/orcae/
overview/Catro), i.e., JA induced in both cell suspensions and
seedlings but not induced by ORCA overexpression in cell
suspensions, were selected for further analysis. Among them,
MVK, PMK, MVD














































































































































Fig. 1. BIS1 is coexpressed with the iridoid pathway genes in C. roseus. (A) Pathways leading to the production of MIAs and triterpenoids in C. roseus.
Genes activated by BIS1 and ORCA3 overexpression are boxed in blue and green, respectively. 7DLGT, 7-deoxyloganetic acid glucosyl transferase; 7DLH,
7-deoxyloganic acid hydroxylase; 8HGO, 8-hydroxygeraniol oxidoreductase; AAS, α-amyrin synthase; AO, amyrin oxidase; DXR, 1-deoxy-5-xylulose-5-phosphate
reductase; FPP, farnesyl pyrophosphate; G3P, glyceraldehyde 3-phosphate; G8O, geraniol-8-oxidase; GES, geraniol synthase; GPP, geranyl diphosphate; HDS,
(E )-4-hydroxy-3-methyl-but-2-enyl pyrophosphate synthase; HMGR, 3-hydroxy-3-methylglutaryl-CoA reductase; IPP, isopentenyl diphosphate; IO, iridoid
oxidase; IS, iridoid synthase; LAMT, loganic acid O-methyltransferase; MECS, 4-diphosphocytidyl-2-C-methyl-D-erythritol 2-phosphate synthase; MEP, 2-C-methyl-
D-erythritol 4-phosphate; MVA, mevalonate; SLS, secologanin synthase; STR, strictosidine synthase; TDC, tryptophan decarboxylase. (B and C) Coexpression
analysis of BIS1, ORCA3, MYC2, and the known MIA and triterpenoid pathway genes. The average linkage hierarchical clustering with Pearson correlation was
used. FKPM values along with Caros and gene ID can be found in SI Appendix, Tables S1 and S2. Blue and yellow denote relative down-regulation and up-
regulation, respectively. (B) Selected RNA-Seq data from the Medicinal Plant Genomics Resource (medicinalplantgenomics.msu.edu). Values were normalized to
the seedling reads. IM, immature leaf; ML, mature leaf. (C) RNA-Seq from the Online Resource for Community Annotation of Eukaryotes (ORCAE) database
from the SmartCell consortium (bioinformatics.psb.ugent.be/orcae/overview/Catro). Values were normalized to the control cell culture (CC_c). CC_JA, JA-treated
cell culture; CC_O2 and CC_O3, cell culture overexpressing ORCA2 and ORCA3. Genes indicated in gray were not expressed in the cell culture.










a bHLH TF belonging to clade IVa of the family (27) (Fig. 1 B
and C and SI Appendix, Fig. S1) was capable of transactivating
pG8O 95.3-fold in a Nicotiana tabacum (tobacco) protoplast-
based screen (Fig. 2A). The gene encoding this bHLH TF, desig-
nated “bHLH Iridoid Synthesis 1” (BIS1; Caros001862), responded
to JA similarly to the genes encoding the enzymes involved in the
iridoid and MIA pathways and those encoding known regulators,
such as ORCA3 and MYC2 (Fig. 1C). Contrary to BIS1, the latter
two transactivated pG8O only by 1.7-fold and 1.1-fold, respectively
(Fig. 2A). Leaf disk assays with agroinfiltrated Nicotiana ben-
thamiana plants confirmed the effect of BIS1 on pG8O (Fig. 2B).
Finally, these results were corroborated by transient transactivation
assays in bombarded C. roseus cells (Fig. 2C).
BIS1 Specifically Transactivates the Iridoid Pathway Branch Upstream
of LAMT. Iridoid genes upstream of LAMT in C. roseus are highly
coexpressed withG8O and thus might potentially be under a similar
regulatory control. To test this hypothesis, we isolated the gene
promoters of geraniol synthase (GES), 8-hydroxygeraniol oxidase
(8HGO), iridoid synthase (IS), iridoid oxidase (IO), 7-deoxy-
loganetic acid glucosyltransferase (7DLGT), 7-deoxyloganic acid
hydroxylase (7DLH), and LAMT from the recently revealed
C. roseus genome sequence (28), as well as of the ORCA3-
dependent gene STR1, and assessed them for transactivation by
BIS1, MYC2, and ORCA3 (Fig. 2). In tobacco protoplasts, BIS1
was able to induce all iridoid promoters 31- to 95-fold, except
for pIO (Fig. 2A). In contrast, ORCA3 only marginally trans-
activated the iridoid promoters, usually by less than twofold,
except for pIS, which was induced 4.9-fold (Fig. 2A). No signif-
icant transactivation with MYC2 was observed for any of the
iridoid promoters. As the minor effect of ORCA3 on these
promoters did not correlate with increased expression of the
corresponding genes in the ORCA3-overexpressing cell line (as
determined by RNA-Seq analysis; Fig. 1C and SI Appendix,
Table S2) (7), we did not further consider it. Conversely, the
promoter of the known ORCA3 target gene STR1 was induced
24.7-fold by ORCA3 and only 1.3-fold by either BIS1 or MYC2
in tobacco protoplasts (Fig. 2A). The effect of ORCA3 on pSTR1
was validated in the N. benthamiana leaf assay, in which BIS1 or
MYC2 slightly repressed the pSTR1-driven reporter expression
(Fig. 2B). The LAMT promoter derivative used here could not
be transactivated by any TF (Fig. 2B). Hence, the action range
of BIS1 is limited to the iridoid branch of the MIA pathway
(up to loganic acid synthesis) and is clearly distinct from that
of ORCA3.
BIS1 Boosts MIA Production in C. roseus Cell Cultures. In contrast to
differentiated C. roseus plant tissues, the C. roseus cell suspension
line MP183L accumulates only trace amounts of secologanin,
strictosidine, or MIAs without exogenous supply of JA or loganin.
In addition and in contrast to the ORCA3-dependent genes, G8O
transcripts could not be detected in wild-type cells, illustrating the
limiting nature of the seco-iridoid pathway in this cell line (14). The
RNA-Seq data analysis confirmed the low transcript accumulation
of all MEP and iridoid genes in nonelicited cells compared with that
of the ORCA3-regulated genes, such as LAMT, SLS1, and STR1
(SI Appendix, Table S2). Overexpression of ORCA3 in this cell line
increased the expression of LAMT, STR, and SLS, among other
genes, but not of the iridoid genes upstream of LAMT (Fig. 1C) (7,
14). Accordingly, an increase in MIA accumulation in the ORCA3-
overexpressing cells could only be achieved after addition of loganin
to the cell culture medium (14).
To evaluate the effect of BIS1 on MIA production and assess
its value as a metabolic engineering tool, we generated three stable
transgenic MP183L suspension cell lines constitutively overex-
pressing BIS1 (Fig. 3). Compared with control lines expressing the
gene encoding the green fluorescent protein (GFP), BIS1 over-
expression resulted in a high up-regulation of MEP genes and
the iridoid genes upstream of LAMT in three independent BIS1
lines, whereas transcript accumulation of ORCA3-dependent genes
remained unaltered (Fig. 3A). This up-regulation was accompanied


























































Fig. 2. BIS1 transactivates iridoid genes in transient assays. (A) Trans-
activation in transfected N. tabacum protoplasts of iridoid and MIA pro-
moters driving firefly luciferase (fLUC) expression by effector plasmids
expressing BIS1, ORCA3, or MYC2. Values in the y axis are normalized fold-
changes relative to protoplasts cotransfected with the reporter constructs
and a pCaMV35S:GUS (GUS) control plasmid. For the normalization pro-
cedure, see SI Appendix, SI Materials and Methods. The error bars designate
SE of the mean (n = 8). (B) Transactivation in agroinfiltrated N. benthamiana
leaves of pG8O and pSTR1 driving fLUC expression by effector plasmids
expressing BIS1, ORCA3, and MYC2. Values are normalized fold-changes
relative to leaves coinfiltrated with the reporter constructs and a pCaMV35S:
GFP (GFP) control plasmid. The error bars designate SE of the mean (n = 8).
(C) Transactivation in bombarded C. roseus MP183L cells of pG8O driving
GUS expression by effector plasmids expressing BIS1 and MYC2. Values are
fold-changes relative to cells cobombarded with the reporter construct and a
pCaMV35S:GFP (GFP) control plasmid. The error bars designate SE of the
mean (n = 3). In all cases, statistical significance was determined by the
















































Fig. 3. BIS1 overexpression boosts MIA production in stably transformed
C. roseus suspension cultures. (A) Expression analysis in transformed cells by
RNA-blot hybridization analysis showing the effect of constitutive over-
expression of BIS1 on selected biosynthetic genes in three independent cell
suspension cultures of C. roseus. RPS9 was used as a reference gene. (B) Ac-
cumulation of (seco)-iridoid and MIA compounds in the BIS1-overexpressing
cell lines. Metabolite levels are indicated in mg·g–1 dry weight. The error bars
designate SE of the mean (n = 3). In control cell lines, no detectable levels of
these compounds accumulated.
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wild-type and control cells, the (seco)-iridoids loganic acid and
secologanin accumulated in the BIS1-overexpressing cells. Likewise,
we observed a strong accumulation of strictosidine, indicating that
the tryptamine levels were not limiting, as well as of the downstream
MIA compounds ajmalicine, serpentine, and tabersonine to levels
previously unreported in untreated MP183L cells. In control cell
lines, none of these MIA compounds accumulated to detectable
levels. Together these data demonstrate that BIS1 overexpression is
sufficient to boost MIA production in C. roseus MP183L cells.
BIS1 Specifically Up-Regulates the Iridoid Genes in C. roseus Hairy
Roots. Overexpression of G8O had previously been reported to
be sufficient to increase MIA accumulation in C. roseus hairy
roots (24). Therefore, we also generated C. roseus hairy roots
that overexpressed BIS1. In contrast to the cell suspensions, MIA
accumulation did not increase in the transgenic hairy root lines
(Fig. 4A), despite clear BIS1 overexpression (Fig. 4B).
Previously, MIA metabolite levels had not been found to in-
crease significantly in ORCA3-overexpressing C. roseus hairy
root lines either, not even after loganin and tryptophan feeding
(23). This observation correlated not only with the anticipated
lack of G8O induction but, unexpectedly, also with unaltered tryp-
tophan decarboxylase (TDC) and repressed strictosidine-β-glucosi-
dase (SGD) expression (23), two ORCA3-inducible genes in cell
cultures (14).
To assess whether analogous flux limitations would occur in
the BIS1-overexpressing roots, we carried out a transcriptome
analysis by RNA-Seq. As in suspension cells, BIS1 overexpression
up-regulated the expression of all iridoid genes upstream of LAMT
(Fig. 4D) but not of the ORCA3 target gene STR1 (Fig. 4C).
Overexpression of BIS1 also resulted in increased transcript accu-
mulation of the genes encoding all MEP pathway enzymes and the
geranyl diphosphate (GPP) synthase small subunit (Fig. 4E and SI
Appendix, Table S2) but in a decreased expression of the ORCA3
target genes LAMT, secologanin synthase (SLS), TDC, and SGD
(Fig. 4C and SI Appendix, Table S2). The latter effect might create a
flux limit and might explain that BIS1 overexpression does not lead
to increased MIA accumulation in hairy roots. Decreased expres-
sion of the ORCA3 target genes was not caused by decreased
expression of ORCA2 or ORCA3, nor of any other known
C. roseus TF encoding gene previously linked with regulation of
the MIA pathway (SI Appendix, Fig. S2), and thus involves
other, yet unknown, regulatory mechanisms.
It is conceivable that the increased MEP pathway activity may
involve widespread reprogramming of terpenoid pathways de-
pendent on MEP-derived IPP and GPP. To assess this, we mined
the RNA-Seq data for genes encoding enzymes involved in
MEP-dependent terpene biosynthesis, encompassing the mono-
terpenoid, diterpenoid (gibberellins), and carotenoid and phy-
tyldiphosphate-reliant (chlorophyll and tocopherol) biosynthetic
pathways. This analysis indicated that none of the above path-
ways was affected by BIS1 overexpression in hairy roots (SI
Appendix, Fig. S3). In concordance with this observation, ex-
pression of the genes involved in these pathways was not affected
by JA elicitation either (SI Appendix, Fig. S3).
C. roseus also produces pentacyclic triterpenoids, such as
ursolate and oleanolate (5, 6), that are synthesized from MVA
pathway-derived IPP. As BIS1 is JA inducible but the C. roseus
triterpenoid pathway genes are not (8), we anticipated that the
triterpenoid pathway genes would not be affected by BIS1
overexpression, as was indeed the case (Fig. 4E). Moreover, the
triterpenoid precursor MVA pathway genes were not induced by
BIS1 overexpression or by JA treatment (Fig. 4E) either, the
latter in contrast to many other plant species (29). Together, this
transcriptome analysis delineates the BIS1 specificity as a tran-
scriptional activator of the iridoid pathway up to loganic acid.
Silencing of BIS1 Reduces MIA Accumulation in Planta. Finally, we
carried out a loss-of-function analysis of BIS1 in two different
systems. First, virus-induced silencing (VIGS) was used to silence
the expression of BIS1 in leaves of the C. roseus cultivar Little
Bright Eyes. Unfortunately, despite several attempts, only a minor
effect on the BIS1 transcript silencing and secologanin accumula-
tion was obtained (SI Appendix, Fig. S4). No difference in down-
stream MIA products, such as strictosidine or vindoline, was
observed. Second, we transformed C. roseus hairy roots with BIS1-
targeting RNAi-silencing constructs. Two stably transformed root
lines with significantly reduced BIS1 mRNA levels were obtained
(SI Appendix, Fig. S4C). In these lines, MIAs accumulated at sig-
nificantly decreased levels (SI Appendix, Fig. S4D). Together these
results support a role for BIS1 in the regulation of the iridoid
pathway in planta.
BIS1 Expression Is Enriched in IPAP-Containing Tissues. The frag-
ments per kilobase of exon per million fragments mapped
(FPKM) values of BIS1 are too low to enable in situ hybridiza-
tion signal detection (2). Therefore, to assess the cell specificity
of BIS1 expression, we generated two sets of C. roseus tissues for





































































































Fig. 4. Expression and metabolite profiling of BIS1-overexpressing C. roseus
hairy roots. (A) Metabolite profiling on the BIS1-overexpressing and control
(GUS) lines. MIA levels are indicated in mg·g–1 dry weight. The error bars
designate SE of the mean (n = 3). (B) qPCR analysis showing BIS1 expression
relative to the control lines set at 1. The error bars designate SE of the mean
(n = 3). Statistical significance was determined by the Student’s t test (*P <
0.05, **P < 0.005, ***P < 0.0005). (C–E) Genome-wide expression profiling
by RNA-Seq analysis. (C and D) Effect on expression of selected MIA (C) and
(seco)-iridoid (D) genes indicated as fold induction relative to the control
lines set at 1. The error bars designate SE of the mean (n = 3). (E) Average
linkage hierarchical clustering of biosynthetic and TF genes. HR_JA0h and
HR_JA24h, hairy roots treated with MeJA for 0 h and 24 h; WT, wild-type
hairy roots (all obtained from bioinformatics.psb.ugent.be/orcae/overview/
Catro). Values were normalized against the WT hairy roots and the
pCaMV35S:GUS (35S:GUS) control hairy roots for the MeJA-treated and the
pCaMV35S:BIS1 (35S:BIS1) samples, respectively. FKPM values along with
Caros and gene ID can be found in SI Appendix, Table S2. Blue and yellow
denote relative down-regulation and up-regulation, respectively.










leaves, from which we dissected the central vein as well as nearly
veinless tissue, whereas the second set was derived from stems, from
which we separated the epidermis from the rest of the stem tissue.
qPCR analysis evidenced that the GES and G8O transcripts were
enriched in the leaf central vein and peeled stem and absent from
the stem epidermis (SI Appendix, Fig. S5), which is in agreement
with their reported internal phloem-associated parenchyma (IPAP)
localization (7, 30, 31). Conversely, SGD transcripts were enriched
in the stem epidermis and veinless leaf and markedly less abundant
in peeled stem and the leaf central vein (SI Appendix, Fig. S5),
which is in agreement with its reported epidermal localization (32).
BIS1 expression was enriched in the leaf central vein and peeled
stem and largely absent from the stem epidermis (SI Appendix, Fig.
S5), hence correlating with the expression of the IPAP-specific
iridoid pathway genes. Furthermore, BIS1 expression was clearly
distinct from that of the ORCA3 gene, which was also strongly
expressed in the stem epidermis (SI Appendix, Fig. S5), thus further
supporting its specificity.
Discussion
Identification of a bHLH-Type Transcriptional Regulator of MIA
Production. MIA production in the medicinal plant C. roseus re-
quires tryptophan and IPP precursors that are shared with the
primary metabolism as well as numerous other specialized me-
tabolite pathways, such as of triterpenoids and sesquiterpenoids
(5, 33). Therefore, biosynthesis of (seco)-iridoids and MIAs re-
quires a tight transcriptional coordination of genes. Our un-
derstanding of this regulatory circuit remains limited to date,
because, in general, only a few transcriptional regulators of the
MEP (or MVA) as well as of the downstream terpenoid path-
ways have been identified (1, 34). Furthermore, MIA production
in C. roseus involves a complex spatial organization, distributed
in at least four cell types, and a marked and concerted elicitation
of the pathway genes by JA treatment (2, 3). This complexity
undoubtedly requires an array of TFs (1), many of which remain
to be discovered.
The expression of several of these TFs may be JA inducible as
part of the JA signaling cascade, as previously shown for ORCA3
and MYC2 (13, 15). This feature has turned out to be a powerful
tool in the past to find pathway-regulating TFs in different plant
species (1, 4, 35) and has been also successfully exploited here to
identify the TF BIS1 as a regulator of the iridoid pathway. BIS1
belongs to clade IVa of the bHLH family (27), which is funda-
mentally different from the much larger MYC2-type TFs, be-
cause its members do not contain a known JAZ-interacting
domain and thus seemingly lack a direct molecular connection
to the currently known primary JA signaling module (1, 36).
Therefore, determination of the exact hierarchical position of
BIS1 in the JA signaling cascade will need further study.
BIS1 and ORCA3 Are Distinct Elements of the MIA Regulatory Circuit.
BIS1 specifically transactivates the promoters of iridoid genes up
to 7DLH and induces their expression in transformed hairy root
and cell suspension cultures. In addition, the MEP genes are also
up-regulated in BIS1-overexpressing cultures, resulting in a co-
ordinated activation of the iridoid and its precursor pathways.
Such coordination of the expression of MEP precursor and ter-
penoid pathway genes has been reported previously and ensures
the coupling of primary with secondary metabolism at the ap-
propriate time and place (37) and is in agreement with the spatial
coexpression of the MEP and iridoid genes in the IPAP cells (31).
To date, only one plant bHLH TF, phytochrome-interacting
factor 5 (PIF5) from Arabidopsis, has been linked with the
transcriptional activation of MEP pathway genes (38). Con-
versely, only one member of the bHLH clade IVa, NAI1 from
Arabidopsis, has been characterized to some extent and has been
reported to be involved in the formation of ER bodies, ER-de-
rived organelles that have only been described in the plant order
of Brassicales, where they are ubiquitous in roots and seedlings
(39). However, NAI1 has not been linked with activation of
MEP, terpenoid, or any (specialized) metabolite biosynthesis
pathway yet. Because of the limited knowledge on TFs belonging
to clade IVa and/or regulating MEP-dependent terpenoid bio-
synthesis (34), it is too early to speculate on the evolutionary
specificity of BIS1.
The regulatory circuit of BIS1 differs markedly from that
controlling the biosynthesis of the indole moiety and subsequent
MIA pathway branches that are under control of ORCA3, which
in turn is controlled by MYC2 (13, 14). Overall, the distinct BIS1
and ORCA3 circuits correlate well with the reported cell type-
specific delineation of the pathway, with BIS1 targeting IPAP-
specific genes. A 533-bp promoter sequence of the G8O gene
had been isolated and shown to be sufficient for responsiveness
to JA in C. roseus hairy roots (16). This promoter fragment
contains several putative TF-binding sites that differ from those
of the ORCA3-dependent gene promoters and was therefore
postulated to be regulated by a different transcriptional cascade,
as corroborated by our study. How and whether the different
circuits interact remains to be resolved. BIS1, MYC2, ORCA3,
and probably other, yet unknown, MIA-regulating TFs are
coinduced by JA elicitation, possibly a prerequisite to guarantee
optimal pathway functioning. Indeed, ORCA3-regulated genes
are not up-regulated by BIS1, and some of them are even down-
regulated. Conversely, in ORCA3-overexpressing cell cultures,
BIS1 and several iridoid genes are down-regulated (Fig. 1C) (7).
Likewise, the effect of ORCA3 overexpression on, for instance,
SGD expression in cell suspension cultures (up) was found to be
opposite to that in hairy root cultures (down) (23). The in-
tegration of the different circuits will need to be taken into ac-
count when engineering the production of MIA compounds in
C. roseus cells.
BIS1 Boosts MIA Production Without Precursor Feeding. Due to the
low in planta abundance of the valuable MIAs and their pre-
cursors, several metabolic engineering and synthetic biology
programs were launched with the aim to create sustainable MIA
resources. In this regard, the recent reconstitutions of the
pathway up to strictosidine in both tobacco (7) and yeast (40)
represent important milestones. However, the use of transcrip-
tional regulators to activate multiple steps is considered most
promising to engineer MIA synthesis in the endogenous plant
source. This belief has been fostered by the discovery of ORCA3
(14), the overexpression of which, however, was not sufficient to
boost MIA production in C. roseus cultures.
In contrast to ORCA3, BIS1 overexpression boosted MIA
production in C. roseus suspension cell cultures in the absence of
exogenous precursors or JA elicitation. Although BIS1 “only”
activated the pathway branch leading to loganic acid, its over-
expression resulted in a dramatic increase, not only of loganic acid
but also of downstream (seco)-iridoid and MIA products, such as
secologanin, strictosidine, ajmalicine, serpentine, and tabersonine.
The biosynthetic route from strictosidine to tabersonine is
largely unknown, but the seven-step biosynthesis pathway from
tabersonine to vindoline has recently been fully elucidated and
reassembled in yeast (41). Until now, production of vindoline in
C. roseus suspension cultures seemed problematic, based on its
complex cell-specific regulation. However, considering that the
tabersonine-to-vindoline pathway can be assembled in a single
yeast cell (41) and that the BIS1-overexpressing cells constitu-
tively accumulate tabersonine, the latter cells may serve as a
promising C. roseus-based platform for further metabolic engi-
neering toward sustainable production of vindoline and, ulti-
mately, vinblastine and vincristine. Successful engineering may
depend not only on the full elucidation and reconstitution of the
pathway at the enzyme level but also on the identification of
additional regulatory TFs of the MIA or its precursor pathways.
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Availability of these TFs may enable the overexpression of a TF
network that resembles the one activated by the plant under
stress conditions and that may lead to high levels of the desired
bioactive MIAs.
Materials and Methods
Plant Material. C. roseus suspension cell line MP183L and cv. Würzburg hairy
roots were used for overexpression and silencing experiments. C. roseus cv.
Little Bright Eyes was used for the VIGS experiments and seedlings, treated
with 1 mM of methyl JA (MeJA) for 24 h, for genomic DNA and RNA isolation.
Generation of DNA Constructs. Constructs were made with the Gateway
Technology (Invitrogen) or restriction enzyme digestion (SI Appendix). Pri-
mers used for cloning are listed in SI Appendix, Table S4.
Transient Transactivation Assays in Nicotiana spp. Transactivation of C. roseus
gene promoters by C. roseus TFs was assessed in transient expression assays
in N. tabacum protoplasts, N. benthamiana leaves, and C. roseus cells
(SI Appendix).
Generation and Profiling of Transformed C. roseus Cultures and Plants.
C. roseus suspension cells, hairy roots, and seedlings were stably and tran-
siently transformed, and the subsequent metabolite and transcript profiling
of the transformed tissues was carried out as described (SI Appendix).
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